1. 1. Aouam K, Bel Hadj Ali H, Youssef M, Chaabane A, Amri M, Boughattas N. A, et al. Carbamazepine‐induced DRESS and HHV6 primary infection: The importance of skin tests. Epilepsia, 2008; 49(9): 1630-33.
2. 2. Chadwick D, Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised doubleblind study. Vigabatrin European Monotherapy Study Group. The Lancet, 1999; 354 (9172):13-19.
3. 3. Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol, 2011; 67(5): 463-470.
4. 4. Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS) Pediatr Dermatol, 2009; 26(5):536-46.
5. 5. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol, 1998; 38(11): 1003-9.